United States Spinal biologics Market Report 2016

December 2016 | 109 pages | ID: UD706A8CB34EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Spinal biologics

Revenue, means the sales value of Spinal biologics

This report studies sales (consumption) of Spinal biologics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Zimmer Holding, Inc.
• Depuy Synthes
• Medtronic, Inc. (U.S.)
• Nuvasive, Inc.
• Stryker Corporation
• Orthofix International N.V.
• K2M, Inc.
• Exactech, Inc.
• Wright Medical Technology, Inc.
• Nutech
• Arthrex, Inc.
• X-Spine Systems, Inc.
• DR PRP USA LLC

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Spinal biologics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Spinal biologics Market Report 2016

1 SPINAL BIOLOGICS OVERVIEW

1.1 Product Overview and Scope of Spinal biologics
1.2 Classification of Spinal biologics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Spinal biologics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Spinal biologics (2011-2021)
  1.4.1 United States Spinal biologics Sales and Growth Rate (2011-2021)
  1.4.2 United States Spinal biologics Revenue and Growth Rate (2011-2021)

2 UNITED STATES SPINAL BIOLOGICS COMPETITION BY MANUFACTURERS

2.1 United States Spinal biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Spinal biologics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Spinal biologics Average Price by Manufactures (2015 and 2016)
2.4 Spinal biologics Market Competitive Situation and Trends
  2.4.1 Spinal biologics Market Concentration Rate
  2.4.2 Spinal biologics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SPINAL BIOLOGICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Spinal biologics Sales and Market Share by Type (2011-2016)
3.2 United States Spinal biologics Revenue and Market Share by Type (2011-2016)
3.3 United States Spinal biologics Price by Type (2011-2016)
3.4 United States Spinal biologics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES SPINAL BIOLOGICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Spinal biologics Sales and Market Share by Application (2011-2016)
4.2 United States Spinal biologics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES SPINAL BIOLOGICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Zimmer Holding, Inc.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Spinal biologics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Zimmer Holding, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Depuy Synthes
  5.2.2 Spinal biologics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Depuy Synthes Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Medtronic, Inc. (U.S.)
  5.3.2 Spinal biologics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Medtronic, Inc. (U.S.) Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Nuvasive, Inc.
  5.4.2 Spinal biologics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Nuvasive, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Stryker Corporation
  5.5.2 Spinal biologics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Stryker Corporation Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Orthofix International N.V.
  5.6.2 Spinal biologics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Orthofix International N.V. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 K2M, Inc.
  5.7.2 Spinal biologics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 K2M, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Exactech, Inc.
  5.8.2 Spinal biologics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Exactech, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Wright Medical Technology, Inc.
  5.9.2 Spinal biologics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Wright Medical Technology, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Nutech
  5.10.2 Spinal biologics Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Nutech Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Arthrex, Inc.
5.12 X-Spine Systems, Inc.
5.13 DR PRP USA LLC

6 SPINAL BIOLOGICS MANUFACTURING COST ANALYSIS

6.1 Spinal biologics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Spinal biologics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Spinal biologics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Spinal biologics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES SPINAL BIOLOGICS MARKET FORECAST (2016-2021)

10.1 United States Spinal biologics Sales, Revenue Forecast (2016-2021)
10.2 United States Spinal biologics Sales Forecast by Type (2016-2021)
10.3 United States Spinal biologics Sales Forecast by Application (2016-2021)
10.4 Spinal biologics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Spinal biologics
Table Classification of Spinal biologics
Figure United States Sales Market Share of Spinal biologics by Type in 2015
Table Application of Spinal biologics
Figure United States Sales Market Share of Spinal biologics by Application in 2015
Figure United States Spinal biologics Sales and Growth Rate (2011-2021)
Figure United States Spinal biologics Revenue and Growth Rate (2011-2021)
Table United States Spinal biologics Sales of Key Manufacturers (2015 and 2016)
Table United States Spinal biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Spinal biologics Sales Share by Manufacturers
Figure 2016 Spinal biologics Sales Share by Manufacturers
Table United States Spinal biologics Revenue by Manufacturers (2015 and 2016)
Table United States Spinal biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Spinal biologics Revenue Share by Manufacturers
Table 2016 United States Spinal biologics Revenue Share by Manufacturers
Table United States Market Spinal biologics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Spinal biologics Average Price of Key Manufacturers in 2015
Figure Spinal biologics Market Share of Top 3 Manufacturers
Figure Spinal biologics Market Share of Top 5 Manufacturers
Table United States Spinal biologics Sales by Type (2011-2016)
Table United States Spinal biologics Sales Share by Type (2011-2016)
Figure United States Spinal biologics Sales Market Share by Type in 2015
Table United States Spinal biologics Revenue and Market Share by Type (2011-2016)
Table United States Spinal biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Spinal biologics by Type (2011-2016)
Table United States Spinal biologics Price by Type (2011-2016)
Figure United States Spinal biologics Sales Growth Rate by Type (2011-2016)
Table United States Spinal biologics Sales by Application (2011-2016)
Table United States Spinal biologics Sales Market Share by Application (2011-2016)
Figure United States Spinal biologics Sales Market Share by Application in 2015
Table United States Spinal biologics Sales Growth Rate by Application (2011-2016)
Figure United States Spinal biologics Sales Growth Rate by Application (2011-2016)
Table Zimmer Holding, Inc. Basic Information List
Table Zimmer Holding, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zimmer Holding, Inc. Spinal biologics Sales Market Share (2011-2016)
Table Depuy Synthes Basic Information List
Table Depuy Synthes Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Depuy Synthes Spinal biologics Sales Market Share (2011-2016)
Table Medtronic, Inc. (U.S.) Basic Information List
Table Medtronic, Inc. (U.S.) Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc. (U.S.) Spinal biologics Sales Market Share (2011-2016)
Table Nuvasive, Inc. Basic Information List
Table Nuvasive, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nuvasive, Inc. Spinal biologics Sales Market Share (2011-2016)
Table Stryker Corporation Basic Information List
Table Stryker Corporation Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporation Spinal biologics Sales Market Share (2011-2016)
Table Orthofix International N.V. Basic Information List
Table Orthofix International N.V. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orthofix International N.V. Spinal biologics Sales Market Share (2011-2016)
Table K2M, Inc. Basic Information List
Table K2M, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table K2M, Inc. Spinal biologics Sales Market Share (2011-2016)
Table Exactech, Inc. Basic Information List
Table Exactech, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exactech, Inc. Spinal biologics Sales Market Share (2011-2016)
Table Wright Medical Technology, Inc. Basic Information List
Table Wright Medical Technology, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wright Medical Technology, Inc. Spinal biologics Sales Market Share (2011-2016)
Table Nutech Basic Information List
Table Nutech Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nutech Spinal biologics Sales Market Share (2011-2016)
Table Arthrex, Inc. Basic Information List
Table Arthrex, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arthrex, Inc. Spinal biologics Sales Market Share (2011-2016)
Table X-Spine Systems, Inc. Basic Information List
Table X-Spine Systems, Inc. Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table X-Spine Systems, Inc. Spinal biologics Sales Market Share (2011-2016)
Table DR PRP USA LLC Basic Information List
Table DR PRP USA LLC Spinal biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table DR PRP USA LLC Spinal biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spinal biologics
Figure Manufacturing Process Analysis of Spinal biologics
Figure Spinal biologics Industrial Chain Analysis
Table Raw Materials Sources of Spinal biologics Major Manufacturers in 2015
Table Major Buyers of Spinal biologics
Table Distributors/Traders List
Figure United States Spinal biologics Production and Growth Rate Forecast (2016-2021)
Figure United States Spinal biologics Revenue and Growth Rate Forecast (2016-2021)
Table United States Spinal biologics Production Forecast by Type (2016-2021)
Table United States Spinal biologics Consumption Forecast by Application (2016-2021)